Table 3

Likely pathogenic variants and other variants identified in patients without a known mutation

Patient IDSexAge (y)ModeClinical featuresGeneTranscriptc.p.InheritanceReferenceFigure
Likely pathogenic variants
 V1.12M11?Ectodermal dysplasiaEDANM_001399.4c.[396+5G>A];[=]p.[0?];[=]MaternalNovelS39
 V2.07M14?AI hypomineralised, hypoplasticMMP20NM_004771.3c.[954-2A>T];[126+6T>G]p.[0?];[0?]Compound heterozygous25 and novelS40
 V2.13F17?AI hypoplastic, hypomatureMMP20NM_004771.3c.[954-2A>T](;)[c.103A>C]p.[0?](;)[R35R]?25 and novelS41
 V2.15M20?Spondyloepiphyseal dysplasiaGALNSNM_000512.4c.[121-31];[935C>G]p.[0?];[T312S]Compound heterozygousNovel and 81S42
 V2.32F26?AI hypomineralised, hypoplasticFAM20ANM_017565.3c.[590-2A>G;590-3C>A](;) [1294G>A]p.[0?](;)[A432T]Maternal and de novo82 and novelS43
 V2.86F6?AI hypoplasticLAMB3NM_000228.2c.[1903C>T];[=]p.[R635*];[=]Maternal, asymptomatic83S44
Cases where only a single pathogenic variant was identified
 V2.49F4?Mucopolysaccharidosis IVAGALNSNM_000512.4c.[1156C>T];[?]p.[R386C];[?]de novo84S45
  • AI, amelogenesis imperfecta; ID, intellectual disability.